RMM Grants Awarded

See where grants have been awarded across Minnesota.
Randy Daughters, PhD
The mission of the Minnesota Regenerative Medicine Education and Outreach Program (MRMEOP) is to facilitate the understanding and integration of…
2019-2020
Patrick Walsh, MS
The goal of this grant is to bring Anatomi Corp's Chrono™ Platform to market. A small portion of this funding will offset overhead costs associated…
2019-2020
Neil Otto, PhD
The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐…
2019-2020
Timothy O'Brien, DVM, PhD
We have developed a novel technology that induces human stem cells to form cartilage. In this project we aim to take the first steps in developing…
2019-2020
Richard Murphy, General Manager
The aim of this grant proposal is to develop cardiovascular devices at Vascudyne with regenerative engineered tissue technology licensed from the…
2019-2020
Ohad Gafni, PhD
Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity…
2019-2020
Dominique Davidow, PhD
Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular…
2019-2020
Frank H. Burton, PhD
This project is performing translational studies on a wound-healing accelerant that has been provisionally patented. Animal studies showed that…
2019-2020
Vanesa Alonso-Camino, PhD
We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor…
2019-2020
Saranya Wyles, MD, PhD
Rapidly growing interest and innovation in the field of regenerative medicine is countered by the limitation in the tools to educate the next-…
2018-2019
Anna Wirta Kosobuski
Encourage Native American youth to achieve high school graduation and pursue post-­secondary education in order to secure a future career in…
2018-2019
Arthur E. Warrington, PhD
A natural human antibody designed to enhance brain and spinal cord remyelination is presently in clinical trial in patients with multiple sclerosis…
2019-2021